Navigation Links
Drug Safety Firm BioSoteria Receives 2009 Best of Business Award
Date:3/25/2010

BioSoteria been selected for the 2009 Best of Business Award in the Commercial Site category by the Small Business Commerce Association (SBCA). The SBCA 2009 Award Program recognizes the top 5% of small businesses throughout the country, identified through statistical research and monthly surveys.

Emeryville, CA (PRWEB) March 25, 2010 -- BioSoteria, Inc., a drug safety services and education firm, announced today that it has been selected for the 2009 Best of Business Award in the Commercial Site category by the Small Business Commerce Association (SBCA).

The SBCA 2009 Award Program recognizes the top 5% of small businesses throughout the country. Using statistical research and information taken from monthly surveys, the SBCA identifies companies that it believes has demonstrated what makes small businesses a vital part of the American economy. Award winners are a valuable asset to their community and exemplify what makes small businesses great.

“I founded BioSoteria in 2007 to provide drug safety services to the community of growing biotechnology companies in the San Francisco area,” said Sally Van Doren, President and CEO of BioSoteria. “The Best of Business Award from SBCA recognizes our success as a service provider to not only Bay-area companies, but to biotechnology and pharmaceutical companies across North America and worldwide. We are pleased to receive this recognition.”

About Small Business Commerce Association (SBCA)
Small Business Commerce Association (SBCA) is a private sector entity that aims to provide tactical guidance in many day-to-day issues that small business owners face. In addition to providing a central repository of small business operational advice, SBCA identifies companies that exemplify what makes small business a vital part of the American economy. For more information, visit the website at www.SBCAAwards.org.

About BioSoteria
From strategic risk management consulting services and world-class pharmacovigilance training and education to full-service drug safety department capabilities, BioSoteria provides unmatched experience, expertise and leadership to support pharmaceutical and biotechnology companies’ efforts to maximize the benefit/risk balance of their products. To learn more about BioSoteria, please visit the company’s website at www.biosoteria.com, or call 1-866-660-5553.

###

Read the full story at http://www.prweb.com/releases/drugsafety/pharmacovigilance/prweb3787924.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related biology technology :

1. American Society of Anesthesiologists: Is Apathy or Avarice Precluding Advocacy of Better Patient Safety?
2. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Good Safety and Clinical Outcomes in Patients with Primary PCI for STEMI
3. Drug Safety Firm BioSoteria Announces Exponential Growth in 2009
4. RFID tags to boost transit worker safety
5. FDA researchers identify new MRI safety risk for patients with pacemakers
6. Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced
7. S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders
8. Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS
9. BioSoteria CEO to Present at Drug Safety Conference
10. Sanofi Pasteur Presents Safety Data on Menactra(R) Vaccine Given to Infants at Infectious Disease Society Meeting
11. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Safety Firm BioSoteria Receives 2009 Best of Business Award 
(Date:2/4/2016)... -- Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: ... in China , today announced that ... on February 4, 2016 a preliminary non-binding proposal letter, ... PKU V-Ming ( Shanghai ) Investment Holdings ... ( Shenzhen ) Fund Management Co., Ltd., ...
(Date:2/3/2016)... 3, 2016   ViaCyte, Inc ., a ... pluripotent stem cell-derived islet replacement therapy for the ... today announced that ViaCyte and Janssen Biotech, Inc., ... & Johnson, have agreed to consolidate the assets ... agreement provides ViaCyte with an exclusive license to ...
(Date:2/3/2016)... NEW YORK and HOLLISTON, Mass., Feb. 3, ... (Nasdaq: HART ), a biotechnology company developing ... esophagus, trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on ... in New York City . ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... Linux and Unix visualization solutions today announced the addition of a powerful “Session ... users to see the current state of the remote Linux desktop or other ...
Breaking Biology Technology:
(Date:2/2/2016)... YORK , Feb. 2, 2016 ... of the bioinformatic market by reviewing the recent ... enabled tools that drive the field forward. Includes ... to: Identify the challenges and opportunities that ... providers and software solution developers, as well as ...
(Date:2/2/2016)... 2, 2016  Based on its recent analysis ... recognizes US-based Intelligent Retinal Imaging Systems (IRIS) with ... for New Product Innovation. IRIS, a prominent cloud-based ... America , is poised to set the ... retinopathy market. The IRIS technology presents superior price-performance ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
Breaking Biology News(10 mins):